Results 1 - 20 of 76 for All Library Resources
Sorted by:
Sorted by:
RelevanceOr hit Enter to replace sort method
- Relevance
- Date-newest
- Date-oldest
- Popularity
- Author
- Title
Show only
| Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
|---|---|---|---|
| 1 |
Material Type: Article
|
|
Characterization of male breast cancer: results of the EORTC 10085/TBCRC/BIG/NABCG International Male Breast Cancer ProgramAnnals of oncology, 2018-02, Vol.29 (2), p.405-417 [Peer Reviewed Journal]2017 European Society for Medical Oncology ;The Author 2017. Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved. For Permissions, please email: journals.permissions@oup.com. 2017 ;The Author 2017. Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved. For permissions, please email: journals.permissions@oup.com. ;ISSN: 0923-7534 ;ISSN: 1569-8041 ;EISSN: 1569-8041 ;DOI: 10.1093/annonc/mdx651 ;PMID: 29092024Full text available |
| 2 |
Material Type: Article
|
|
Pathological complete response after neoadjuvant chemotherapy is an independent predictive factor irrespective of simplified breast cancer intrinsic subtypes: a landmark and two-step approach analyses from the EORTC 10994/BIG 1-00 phase III trialAnnals of oncology, 2014-06, Vol.25 (6), p.1128-1136 [Peer Reviewed Journal]2014 European Society for Medical Oncology ;2015 INIST-CNRS ;The Author 2014. Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved. For permissions, please email: journals.permissions@oup.com. ;The Author 2014. Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved. For permissions, please email: journals.permissions@oup.com. 2014 ;ISSN: 0923-7534 ;ISSN: 1569-8041 ;EISSN: 1569-8041 ;DOI: 10.1093/annonc/mdu118 ;PMID: 24618153Full text available |
| 3 |
Material Type: Article
|
|
Pazopanib in advanced vascular sarcomas: an EORTC Soft Tissue and Bone Sarcoma Group (STBSG) retrospective analysisActa oncologica, 2017-01, Vol.56 (1), p.88-92 [Peer Reviewed Journal]ISSN: 0284-186X ;EISSN: 1651-226X ;DOI: 10.1080/0284186x.2016.1234068 ;PMID: 27838944Full text available |
| 4 |
Material Type: Article
|
|
Long-term responders and survivors on pazopanib for advanced soft tissue sarcomas: subanalysis of two European Organisation for Research and Treatment of Cancer (EORTC) clinical trials 62043 and 62072Annals of oncology, 2014-03, Vol.25 (3), p.719-724 [Peer Reviewed Journal]2014 European Society for Medical Oncology ;2015 INIST-CNRS ;The Author 2014. Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved. For permissions, please email: journals.permissions@oup.com. 2014 ;ISSN: 0923-7534 ;EISSN: 1569-8041 ;DOI: 10.1093/annonc/mdt586 ;PMID: 24504442Full text available |
| 5 |
Material Type: Article
|
|
Trastuzumab versus observation for HER2 nonamplified early breast cancer with circulating tumor cells (EORTC 90091-10093, BIG 1-12, Treat CTC): a randomized phase II trialAnnals of oncology, 2018-08, Vol.29 (8), p.1777-1783 [Peer Reviewed Journal]2018 THE AUTHORS ;The Author(s) 2018. Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved. For permissions, please email: journals.permissions@oup.com. 2018 ;ISSN: 0923-7534 ;EISSN: 1569-8041 ;DOI: 10.1093/annonc/mdy211 ;PMID: 29893791Full text available |
| 6 |
Material Type: Article
|
|
Final analysis of the randomized trial on imatinib as an adjuvant in localized gastrointestinal stromal tumors (GIST) from the EORTC Soft Tissue and Bone Sarcoma Group (STBSG), the Australasian Gastro-Intestinal Trials Group (AGITG), UNICANCER, French Sarcoma Group (FSG), Italian Sarcoma Group (ISG), and Spanish Group for Research on Sarcomas (GEIS)Annals of oncology, 2021-04, Vol.32 (4), p.533-541 [Peer Reviewed Journal]2021 ;Copyright © 2021. Published by Elsevier Ltd. ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0923-7534 ;ISSN: 1569-8041 ;EISSN: 1569-8041 ;DOI: 10.1016/j.annonc.2021.01.004 ;PMID: 33482247Full text available |
| 7 |
Material Type: Article
|
|
Immunohistochemical versus molecular (BluePrint and MammaPrint) subtyping of breast carcinoma. Outcome results from the EORTC 10041/BIG 3-04 MINDACT trialBreast cancer research and treatment, 2018, Vol.167 (1), p.123-131 [Peer Reviewed Journal]Springer Science+Business Media, LLC 2017 ;COPYRIGHT 2018 Springer ;Breast Cancer Research and Treatment is a copyright of Springer, (2017). All Rights Reserved. ;ISSN: 0167-6806 ;EISSN: 1573-7217 ;DOI: 10.1007/s10549-017-4509-9 ;PMID: 28929359Full text available |
| 8 |
Material Type: Article
|
|
Early discontinuation of PD-1 blockade upon achieving a complete or partial response in patients with advanced melanoma: the multicentre prospective Safe Stop trialBMC cancer, 2021-03, Vol.21 (1), p.323-323, Article 323 [Peer Reviewed Journal]COPYRIGHT 2021 BioMed Central Ltd. ;COPYRIGHT 2021 BioMed Central Ltd. ;2021. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2021 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-021-08018-w ;PMID: 33765967Full text available |
| 9 |
Material Type: Article
|
|
Guidelines for time-to-event end point definitions in sarcomas and gastrointestinal stromal tumors (GIST) trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials)Annals of oncology, 2015-05, Vol.26 (5), p.865-872 [Peer Reviewed Journal]2014 European Society for Medical Oncology ;The Author 2014. Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved. For permissions, please email: journals.permissions@oup.com. ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0923-7534 ;EISSN: 1569-8041 ;DOI: 10.1093/annonc/mdu360 ;PMID: 25070543Full text available |
| 10 |
Material Type: Article
|
|
Identification of SNPs associated with response of breast cancer patients to neoadjuvant chemotherapy in the EORTC-10994 randomized phase III trialThe pharmacogenomics journal, 2015-02, Vol.15 (1), p.63-68 [Peer Reviewed Journal]COPYRIGHT 2015 Nature Publishing Group ;Copyright Nature Publishing Group Feb 2015 ;Macmillan Publishers Limited 2015. ;ISSN: 1470-269X ;EISSN: 1473-1150 ;DOI: 10.1038/tpj.2014.24 ;PMID: 24958282Full text available |
| 11 |
Material Type: Article
|
|
The impact of a misspecified random-effects distribution on the estimation and the performance of inferential procedures in generalized linear mixed modelsStatistics in medicine, 2008-07, Vol.27 (16), p.3125-3144 [Peer Reviewed Journal]Copyright © 2007 John Wiley & Sons, Ltd. ;ISSN: 0277-6715 ;EISSN: 1097-0258 ;DOI: 10.1002/sim.3157 ;PMID: 18069726Full text available |
| 12 |
Material Type: Article
|
|
Doxorubicin-based adjuvant chemotherapy in soft tissue sarcoma: pooled analysis of two STBSG-EORTC phase III clinical trialsAnnals of oncology, 2014-12, Vol.25 (12), p.2425-2432 [Peer Reviewed Journal]2014 European Society for Medical Oncology ;2015 INIST-CNRS ;The Author 2014. Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved. For permissions, please email: journals.permissions@oup.com. ;ISSN: 0923-7534 ;EISSN: 1569-8041 ;DOI: 10.1093/annonc/mdu460 ;PMID: 25294887Full text available |
| 13 |
Material Type: Article
|
|
Statistical methodology for personalized medicine: New developments at EORTC Headquarters since the turn of the 21st CenturyEuropean journal of cancer supplements, 2012-03, Vol.10 (1), p.13-19 [Peer Reviewed Journal]European Organisation for Research and Treatment of Cancer ;2012 European Organisation for Research and Treatment of Cancer ;ISSN: 1359-6349 ;EISSN: 1878-1217 ;DOI: 10.1016/S1359-6349(12)70005-8Full text available |
| 14 |
Material Type: Article
|
|
Testing for misspecification in generalized linear mixed modelsBiostatistics (Oxford, England), 2010-10, Vol.11 (4), p.771-786 [Peer Reviewed Journal]Copyright Oxford Publishing Limited(England) Oct 2010 ;ISSN: 1465-4644 ;EISSN: 1468-4357 ;DOI: 10.1093/biostatistics/kxq019 ;PMID: 20407039Full text available |
| 15 |
Material Type: Article
|
|
Soft tissue and visceral sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upAnnals of oncology, 2014-09, Vol.25 Suppl 3, p.iii102-iii112 [Peer Reviewed Journal]ISSN: 0923-7534 ;EISSN: 1569-8041 ;DOI: 10.1093/annonc/mdu254 ;PMID: 25210080Full text available |
| 16 |
Material Type: Article
|
|
Gastrointestinal stromal tumours: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upAnnals of oncology, 2014-09, Vol.25 Suppl 3, p.iii21-iii26 [Peer Reviewed Journal]ISSN: 0923-7534 ;EISSN: 1569-8041 ;DOI: 10.1093/annonc/mdu255 ;PMID: 25210085Full text available |
| 17 |
Material Type: Article
|
|
Evolution in neutrophil-to-lymphocyte ratio (NLR) among advanced soft tissue sarcoma (STS) patients treated with pazopanib within EORTC 62043/62072 trialsAnnals of oncology, 2017-09, Vol.28, p.v531 [Peer Reviewed Journal]ISSN: 0923-7534 ;EISSN: 1569-8041 ;DOI: 10.1093/annonc/mdx387.028Full text available |
| 18 |
Material Type: Article
|
|
Bone sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upAnnals of oncology, 2014-09, Vol.25 Suppl 3, p.iii113-iii123 [Peer Reviewed Journal]ISSN: 0923-7534 ;EISSN: 1569-8041 ;DOI: 10.1093/annonc/mdu256 ;PMID: 25210081Full text available |
| 19 |
Material Type: Article
|
|
Early discontinuation of PD-1 blockade upon achieving a complete or partial response in patients with advanced melanoma: the multicentre prospective Safe Stop trialinfo:eu-repo/semantics/OpenAccess ;ISSN: 1471-2407 ;EISSN: 1471-2407Full text available |
| 20 |
Material Type: Article
|
|
EORTC experience with advanced/metastatic epithelioid sarcoma patients treated in prospective trials: Clinical profile and response to systemic therapyAnnals of oncology, 2017-09, Vol.28, p.v528 [Peer Reviewed Journal]ISSN: 0923-7534 ;EISSN: 1569-8041 ;DOI: 10.1093/annonc/mdx387.023Full text available |
Results 1 - 20 of 76 for All Library Resources
Sorted by:
Sorted by:
RelevanceOr hit Enter to replace sort method
- Relevance
- Date-newest
- Date-oldest
- Popularity
- Author
- Title
Personalize your results
Refine Search Results
Expand My Results
Show only
Refine My Results
Creation Date
- Before 2010 (6)
- 2010 To 2012 (9)
- 2013 To 2015 (18)
- 2016 To 2019 (25)
- After 2019 (19)
-
More options
New Records
Subject
- Humans (21)
- Oncology (21)
- Life Sciences & Biomedicine (20)
- Science & Technology (20)
- Female (12)
- Prognosis (11)
- Adult (11)
- Aged (9)
- Middle Aged (9)
- Soft Tissue Sarcoma (7)
- Male (7)
- Treatment Outcome (7)
- Hematology (6)
- Follow-Up Studies (6)
- Chemotherapy (6)
- Medicin Och Hälsovetenskap (6)
- Disease-Free Survival (6)
- Ifosfamide (5)
- Breast Cancer (5)
- Clinical Medicine (5)
-
More options
Databases
- GFMER Free Medical Journals (32)
- MEDLINE (21)
- Leiden University Repository (19)
- HighWire Press (Free Journals) (9)
- Lirias (KU Leuven Association) (8)
- ProQuest Central (8)
- SWEPUB Freely available online (6)
- PubMed Central (5)
- DOAJ Directory of Open Access Journals (4)
- White Rose Research Repository (4)
- ROAD: Directory of Open Access Scholarly Resources (3)
- Springer Nature OA/Free Journals (2)
- Utrecht University Repository (1)
- Nature Open Access (1)
- Free E- Journals (1)
- UCL Discovery (1)
- Hyper Article en Ligne (HAL) (Open Access) (1)
- Coronavirus Research Database (1)
-
More options
Journal Title
|
||||
 |
INSPIRE LIBRARY - TON DUC THANG UNIVERSITY |  |
(84-028) 37 755 057 | Feedback |
| 19 Nguyen Huu Tho St. Dist.7, HCM |  |
thuvien@tdtu.edu.vn | ||